Global Meglumine Competitive Landscape Professional Research Report 2025
Research SummaryMeglumine, also known as N-methylglucamine, is a chemical compound that belongs to the class of amino sugars. It is derived from glucose through a process called methylation and has a chemical formula C7H17NO5. Meglumine is commonly used in pharmaceuticals as a solubilizing agent or an excipient to improve the solubility and stability of certain drugs. It is particularly useful for enhancing the water solubility of poorly soluble substances, allowing for the formulation of injectable or oral preparations. Meglumine is considered safe for human use and is often used in various medical imaging procedures, including contrast media for X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI). Due to its non-toxic nature and ability to enhance drug properties, meglumine has found broad application in the pharmaceutical industry and is an important component in the development of many therapeutic and diagnostic products.
According to DIResearch's in-depth investigation and research, the global Meglumine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Meglumine include Merck, Tianma, Libang Healthcare Group, New Hualian Pharm etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Meglumine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Meglumine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Meglumine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Meglumine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Meglumine Include:
Merck
Tianma
Libang Healthcare Group
New Hualian Pharm
Meglumine Product Segment Include:
Diatrizoate Meglumine
Lothalamate Meglumine
Lodipamide Meglumine
Meglumine Product Application Include:
Cosolvent
Contrast agent
Other
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Meglumine Industry PESTEL Analysis
Chapter 3: Global Meglumine Industry Porter’s Five Forces Analysis
Chapter 4: Global Meglumine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Meglumine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Meglumine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Meglumine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Meglumine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Meglumine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Meglumine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Meglumine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Meglumine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources